Poultry Antibiotic Market Synopsis:
Poultry Antibiotic Market Size Was Valued at USD 2.1 Billion in 2023, and is Projected to Reach USD 3.37 Billion by 2032, Growing at a CAGR of 6.02% From 2024-2032.
Poultry Antibiotic Market refers to the industry that deals in antibiotic products for use with poultry to guard, treat or eradicate diseases resulting from bacterial infections. The above antibiotics are used in poultry rearing business for rapid growth, better feed utilisation and health status of the birds, hence increasing the production rate of the poultry firms. The market involves categories of antibiotics especially feed antibiotics, water-soluble antibiotics, and intravenous drugs.
Market for antibiotics used in poultry is considered as significant in the global market in the poultry business due to the growing demand for poultry products such as chicken, turkey and eggs across the world. Poultry diseases such as Salmonella, E. coli and Avian Influenza should be controlled through use of antibiotics to lead to healthier chicken and better yield. With the advancement and increased scale of poultry farming, and corresponding increased consumption of poultry products worldwide people, antibiotics are considered valuable for controlling diseases, improving performance and minimizing production losses.
However, much attention has recently been drawn to cases where antibiotic agents were used in animals freely especially in poultry farming. This has extended to fashion a culture of antibiotic resistance in bacteria, which is of a great threat to both animals and humanity. Two; Consequently, global regulatory authorities such as Food and Drug Administration of America, World Health Organization, and The European Union are placing more controls and setting higher standards on degrees to be implemented on use of antibiotics in enhancing poultry farming. They are thereby prodding the industry towards developing non-hormonal and non-antibiotic growth promoters like probiotics, organic acids and essential oils indicating that the industry may soon trend towards sustainability.

Poultry Antibiotic Market Trend Analysis:
Shift Toward Antimicrobial Resistance (AMR) Solutions
- Another trend that have recently emerged in the field of poultry antibiotic is the growing concern with antimicrobial resistance tendencies. Due to the increase in Antibiotic Mis peruse and Resistance AMR around the globe and its possible effect on the efficacy of antibiotics for both human and animals especially poultry, there was a drastic change to more extensive usage of antibiotics responsibly in poultry. It’s now prohibited and governments are prescribing non-antibiotic agents such as vaccines, prebiotics, and probiotics.
- Business entities in the market are increasingly directing their research and development activities towards novel AMR-resistant antibiotics and other therapies, and relatively recent advancements include bacteriophages, photobiotic as well as other feed supplements. This outlook is also expected to rise in the following years as more animal management strategies that prevent the utilization of these antibiotics are embraced.
Expanding Poultry Production in Emerging Markets
- One of the most significant opportunities for the growth of poultry antibiotics are the increasing production of poultry in the emergent countries. Consequently, as more people urbanize and gain disposable income in APAC, LATAM and the Middle East, poultry demand will increase significantly. Currently, the world’s leading nations including China, India, Brazil and Mexico are expanding their production to fit both their people demand as well as export markets.
- Therefore, the demand for the antibiotic essentials for the wellbeing and fattening of poultry is anticipated to rise. Also, due to increasing consciousness about animal rights and food safety there will be a subsequent requirement of antibiotics that are effective as well as complied with global regulatory aspects. It means that the manufacturers of antibiotics get an opportunity to diversify their products in the emerging markets.
Poultry Antibiotic Market Segment Analysis:
Poultry Antibiotic Market is Segmented on the basis of Product Type, Application, End User, and Region.
By Product Type, Tetracyclines segment is expected to dominate the market during the forecast period
- By type of antibiotic used in poultry farming, the market for poultry antibiotics can be classified. Tetracyclines are taken as one of the first choices of antibiotics since they are potent against a large number of bacteria. They are good in managing respiratory diseases, gastrointestinal diseases and many other bacterial conditions in poultry. The second is Penicillin – broad pharmaceutical category which is intended for use in case of diseases associated with gram-positive bacteria including streptococcal and staphylococcal infections. This is result is contributed by the increasing concern in antibiotic resistance even as Penicillin goes into high demand in the poultry health practice.
- Macrolides are also widely used in poultry farming; for respiratory and digestive systems illnesses treatment. These antibiotics are used for this reason, that they have selective action against certain pathogens and do not influence the integrated bacteria population of the gastrointestinal tract. Sulphonamides on the other hand are used in both prophylactic and therapeutic use in multiple infections where both gram positive and negative bacteria are involved. Aminoglycosides are recognized for their activity against serious bacterial infections particularly of Gram-negative origin. Other antibiotics this included “Others” which are new types of old antibiotics, new developments in bird’s antibiotics or antibiotics that are not so commonly used but used to treat specific infections or conditions of poultry. This wide spectrum of antibiotics makes it possible for poultry farmers to provides for the health needs of their poultry stock and at the same time continue with production.
By Application, Disease Treatment segment expected to held the largest share
- Disease treatment is a key factor that defines the demand for poultry antibiotics and remains the primary source for the segment. Antibiotics are widely used to with success in controlling bacterial diseases in poultry since its absence leads to high mortality and low production. It is noteworthy that bacterial infections like Salmonella, E. coli and respiratory tracts ones are cured with use of antibiotic. Disease treatment for poultry prevents a lot of work in the removal of affected birds, and makes poultry farming more effective. Due to importance of this application in ensuring quality and safety of poultry products, it forms a significant segment of the market.
- Another important use of poultry antibiotic is growth promotion apart from eradicating or controlling the diseases. I knew antibiotics are used to enhance the feed conversion ratios and growth to fasten the desire weight of the birds to market weight. The use of antibiotics as growth promoters has recently come under considerable pressure due to problems associated with resistance but is still widespread in several areas. Though, as legal restraints get concrete – especially in the European Union and North America – there is a gradual transition to using substitutes such as probiotics and growth promoters instead of antibiotics which promote growth. In this regard, there can be no denial that antibiotics are still a very useful tool in furthering production and subsequent profitable generation of poultry business across the world.
Poultry Antibiotic Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- According to the requirement from different regions, in 2023 the poultry antibiotic market share in North America is the biggest one. It is expected that region will contribute to have 35%-40% of global market share majorly due to high poultry consumption, enhanced farming technique and presence of large number of poultry producers. The U.S has tremendous demand for poultry antibiotics, primarily because of its efficient poultry business and inclination more towards animal health and consequent output.
- However, the region is also experiencing a rising regulatory pressure to lower antibiotic consumption in animal farming following alarm over antibiotic resistant strains. The market share observed in North America features the equilibrium between the need for an increased volume of poultry production and legislation regulation. Some of the new regulatory policies have therefore been aimed at forcing the U.S towards the production of the new generation of antibiotics to make a replacement and at the same ensure optimum production of poultry.
Active Key Players in the Poultry Antibiotic Market:
- Adisseo (France)
- Animal Pharm (UK)
- Archer Daniels Midland Company (USA)
- BASF SE (Germany)
- Bayer AG (Germany)
- Boehringer Ingelheim (Germany)
- Ceva Santé Animal (France)
- Elanco Animal Health (USA)
- Huvepharma (Bulgaria)
- Indian Immunologicals Limited (India)
- Merck & Co., Inc. (USA)
- Novartis Animal Health (Switzerland)
- Phibro Animal Health Corporation (USA)
- Zoetis Inc. (USA)
- Vetoquinol S.A. (France), and Other Active Players.
Global Poultry Antibiotic Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.1 Billion |
Forecast Period 2024-32 CAGR: |
6.02% |
Market Size in 2032: |
USD 3.37 Billion |
Segments Covered: |
By Product Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Poultry Antibiotic Market by Product Type (2018-2032)
4.1 Poultry Antibiotic Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Tetracyclines
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Penicillin
4.5 Macrolides
4.6 Sulphonamides
4.7 Aminoglycosides
4.8 Others
Chapter 5: Poultry Antibiotic Market by Application (2018-2032)
5.1 Poultry Antibiotic Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Disease Treatment
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Growth Promotion
Chapter 6: Poultry Antibiotic Market by End User (2018-2032)
6.1 Poultry Antibiotic Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Poultry Farms
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Veterinary Clinics
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Poultry Antibiotic Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ADISSEO (FRANCE)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ANIMAL PHARM (UK)
7.4 ARCHER DANIELS MIDLAND COMPANY (USA)
7.5 BASF SE (GERMANY)
7.6 BAYER AG (GERMANY)
7.7 BOEHRINGER INGELHEIM (GERMANY)
7.8 CEVA SANTÉ ANIMALE (FRANCE)
7.9 ELANCO ANIMAL HEALTH (USA)
7.10 HUVEPHARMA (BULGARIA)
7.11 INDIAN IMMUNOLOGICALS LIMITED (INDIA)
7.12 MERCK & CO. INC. (USA)
7.13 NOVARTIS ANIMAL HEALTH (SWITZERLAND)
7.14 PHIBRO ANIMAL HEALTH CORPORATION (USA)
7.15 ZOETIS INC. (USA)
7.16 VETOQUINOL S.A. (FRANCE)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Poultry Antibiotic Market By Region
8.1 Overview
8.2. North America Poultry Antibiotic Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size by Product Type
8.2.4.1 Tetracyclines
8.2.4.2 Penicillin
8.2.4.3 Macrolides
8.2.4.4 Sulphonamides
8.2.4.5 Aminoglycosides
8.2.4.6 Others
8.2.5 Historic and Forecasted Market Size by Application
8.2.5.1 Disease Treatment
8.2.5.2 Growth Promotion
8.2.6 Historic and Forecasted Market Size by End User
8.2.6.1 Poultry Farms
8.2.6.2 Veterinary Clinics
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Poultry Antibiotic Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size by Product Type
8.3.4.1 Tetracyclines
8.3.4.2 Penicillin
8.3.4.3 Macrolides
8.3.4.4 Sulphonamides
8.3.4.5 Aminoglycosides
8.3.4.6 Others
8.3.5 Historic and Forecasted Market Size by Application
8.3.5.1 Disease Treatment
8.3.5.2 Growth Promotion
8.3.6 Historic and Forecasted Market Size by End User
8.3.6.1 Poultry Farms
8.3.6.2 Veterinary Clinics
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Poultry Antibiotic Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size by Product Type
8.4.4.1 Tetracyclines
8.4.4.2 Penicillin
8.4.4.3 Macrolides
8.4.4.4 Sulphonamides
8.4.4.5 Aminoglycosides
8.4.4.6 Others
8.4.5 Historic and Forecasted Market Size by Application
8.4.5.1 Disease Treatment
8.4.5.2 Growth Promotion
8.4.6 Historic and Forecasted Market Size by End User
8.4.6.1 Poultry Farms
8.4.6.2 Veterinary Clinics
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Poultry Antibiotic Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size by Product Type
8.5.4.1 Tetracyclines
8.5.4.2 Penicillin
8.5.4.3 Macrolides
8.5.4.4 Sulphonamides
8.5.4.5 Aminoglycosides
8.5.4.6 Others
8.5.5 Historic and Forecasted Market Size by Application
8.5.5.1 Disease Treatment
8.5.5.2 Growth Promotion
8.5.6 Historic and Forecasted Market Size by End User
8.5.6.1 Poultry Farms
8.5.6.2 Veterinary Clinics
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Poultry Antibiotic Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size by Product Type
8.6.4.1 Tetracyclines
8.6.4.2 Penicillin
8.6.4.3 Macrolides
8.6.4.4 Sulphonamides
8.6.4.5 Aminoglycosides
8.6.4.6 Others
8.6.5 Historic and Forecasted Market Size by Application
8.6.5.1 Disease Treatment
8.6.5.2 Growth Promotion
8.6.6 Historic and Forecasted Market Size by End User
8.6.6.1 Poultry Farms
8.6.6.2 Veterinary Clinics
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Poultry Antibiotic Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size by Product Type
8.7.4.1 Tetracyclines
8.7.4.2 Penicillin
8.7.4.3 Macrolides
8.7.4.4 Sulphonamides
8.7.4.5 Aminoglycosides
8.7.4.6 Others
8.7.5 Historic and Forecasted Market Size by Application
8.7.5.1 Disease Treatment
8.7.5.2 Growth Promotion
8.7.6 Historic and Forecasted Market Size by End User
8.7.6.1 Poultry Farms
8.7.6.2 Veterinary Clinics
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Global Poultry Antibiotic Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.1 Billion |
Forecast Period 2024-32 CAGR: |
6.02% |
Market Size in 2032: |
USD 3.37 Billion |
Segments Covered: |
By Product Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Poultry Antibiotic Market research report is 2024-2032.
Adisseo (France), Animal Pharm (UK), Archer Daniels Midland Company (USA), BASF SE (Germany), Bayer AG (Germany), Boehringer Ingelheim (Germany), Ceva Santé Animale (France), Elanco Animal Health (USA), Huvepharma (Bulgaria), Indian Immunologicals Limited (India), Merck & Co., Inc. (USA), Novartis Animal Health (Switzerland), Phibro Animal Health Corporation (USA), Zoetis Inc. (USA), Vetoquinol S.A. (France), and Other Active Players.
The Poultry Antibiotic Market is segmented into Product Type, Application, End User and region. By Product Type, the market is categorized into Tetracyclines, Penicillin, Macrolides, Sulphonamides, Aminoglycosides, Others), Application, the market is categorized into (Disease Treatment, Growth Promotion), End User, the market is categorized into (Poultry Farms, Veterinary Clinics. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Poultry Antibiotic Market refers to the industry that deals in antibiotic products for use with poultry to guard, treat or eradicate diseases resulting from bacterial infections. The above antibiotics are used in poultry rearing business for rapid growth, better feed utilisation and health status of the birds, hence increasing the production rate of the poultry firms. The market involves categories of antibiotics especially feed antibiotics, water-soluble antibiotics, and intravenous drugs.
Poultry Antibiotic Market Size Was Valued at USD 2.1 Billion in 2023, and is Projected to Reach USD 3.37 Billion by 2032, Growing at a CAGR of 6.02% From 2024-2032.